Nighttime Light Exposure Linked to Objective Sleep Disruptions in Schizophrenia Patients from LENS Study

Study Examines Nighttime Light and Sleep in Schizophrenia

A new cross-sectional analysis from the Light Exposure and Neurobiology in Schizophrenia (LENS) study reveals significant associations between nighttime light exposure and objective sleep parameters in patients with schizophrenia. The research, published online on June 23, 2026, in Psychiatry Research, highlights how even modest levels of light at night can disrupt sleep efficiency, total sleep time, and other measurable aspects of rest, while subjective reports show less clear connections.

The study involved 225 outpatients diagnosed with schizophrenia, drawing from recruitment at Okehazama Hospital and Fujita Mental Care Satellite Zengo between March and November 2024. Researchers measured nighttime light exposure using both wrist-worn actigraphy devices and bedside portable photometers, alongside subjective assessments via the Pittsburgh Sleep Quality Index and objective sleep tracking over seven consecutive days.

Background on Sleep Challenges in Schizophrenia

Schizophrenia, a chronic neuropsychiatric condition marked by hallucinations, delusions, and social withdrawal, frequently co-occurs with sleep disturbances. Prior estimates suggest that around half of individuals with the disorder face difficulties initiating or maintaining sleep. These issues link to reduced quality of life, intensified symptoms, cognitive impairments, metabolic problems, and even elevated risks of suicidal thoughts.

Circadian rhythms, the body's internal clock regulating sleep-wake cycles, play a central role. Disruptions from artificial lighting, which has altered natural day-night patterns, contribute to broader health concerns including mental health disorders. In schizophrenia specifically, mismatched light exposure patterns have been tied to irregular sleep timing and higher hospitalization risks in earlier investigations.

Methods and Measurement Approach

Participants, with a median age of 50 years and 45.3 percent female, wore actigraphy devices to capture both light levels and sleep metrics objectively. Bedside photometers provided an additional environmental light reading from bedtime to rising time. Nighttime illuminance medians reached 1.4 lux via actigraphy and 4.1 lux via photometer, with wide interquartile ranges indicating variability across individuals.

Statistical adjustments accounted for potential confounders such as age, sex, medication use, and other factors. Quartile comparisons of light exposure allowed researchers to identify dose-response relationships with sleep outcomes.

Key Findings on Objective Sleep Metrics

Higher nighttime light exposure correlated strongly with poorer objective sleep. Individuals in the highest quartile of actigraphy-measured illuminance experienced sleep efficiency reduced by 10 percentage points, total sleep time shortened by over 55 minutes, sleep onset latency extended, and wake after sleep onset increased by 31 minutes compared to the lowest quartile. Similar patterns emerged with photometer data.

These objective disruptions occurred independently of several confounding variables, underscoring a robust link. Median baseline sleep efficiency stood at 83.6 percent, total sleep time at 427 minutes, with notable variability in onset and wake periods.

Photo by National Cancer Institute on Unsplash

Discrepancy Between Subjective and Objective Measures

Interestingly, subjective sleep quality assessed through standard questionnaires did not show significant ties to nighttime light levels. This mismatch between patient-reported experiences and device-measured realities points to potential sleep state misperception common in schizophrenia populations. It emphasizes the value of combining both assessment types in clinical and research settings.

Implications for Circadian Health and Mental Wellness

The findings reinforce how light at night can suppress melatonin and shift circadian timing, exacerbating sleep fragmentation in vulnerable groups. For schizophrenia patients already prone to such issues, minimizing evening light exposure emerges as a modifiable factor worth clinical attention. Interventions like optimized bedroom lighting, blue-light filters, or timed light avoidance could complement existing treatments.

Broader research on light exposure and psychiatric outcomes supports these observations. Studies have connected greater nighttime light to increased risks of mood disorders, psychosis, and diminished well-being across general populations.

Context from Related Research and Interventions

Complementary work on circadian lighting in inpatient schizophrenia settings has demonstrated improvements in psychiatric symptom scores and cognitive measures, with gender-specific patterns noted in some trials. Such approaches suggest potential for light-based therapies to enhance outcomes beyond sleep alone.

The LENS study builds on prior cohort analyses linking light exposure patterns to sleep quality in related conditions like bipolar disorder, extending insights specifically to schizophrenia outpatients.

Future Directions and Research Needs

While cross-sectional data establishes associations, longitudinal designs are essential to determine causality and explore whether reducing nighttime light improves long-term sleep and symptom trajectories. The authors call for expanded studies incorporating diverse populations, detailed medication profiles, and wearable technologies for real-world monitoring.

Funding from JSPS KAKENHI and the Takeda Science Foundation supported the work, with no conflicts declared by the team. Data availability upon reasonable request facilitates further analysis by the research community.

Photo by Hirzul Maulana on Unsplash

Relevance to Academic and Clinical Practice

This publication adds to the growing body of evidence on environmental influences on severe mental illness. For researchers and clinicians in psychiatry, sleep medicine, and chronobiology, it highlights opportunities for interdisciplinary collaboration. Universities and research institutions continue to advance such inquiries through dedicated centers focused on circadian science and mental health.

Practical takeaways include routine screening for light exposure in sleep assessments for schizophrenia patients and patient education on creating darker sleep environments. These steps align with holistic care models emphasizing lifestyle factors alongside pharmacotherapy.

Accessing the Full Publication

The complete study, including detailed tables, statistical models, and author contributions, appears in Psychiatry Research. Lead contributors include Ryota Miyake, Yuichi Esaki, Rina Taniguchi, Kenji Obayashi, Keigo Saeki, Soji Tsuboi, Kiyoshi Fujita, Nakao Iwata, and Tsuyoshi Kitajima.